A20 attenuated hypoxia-induced pulmonary arterial hypertension by inhibiting NF-κB activation and pulmonary artery smooth muscle cell proliferation [19, 49]. This evidence concerns the gene TNFAIP3 and pulmonary arterial hypertension.